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Molecular Biology of Keratinocyte
Differentiation
by Richard Leon Eckert* and Ellen Anne Rorket
Epidermal keratinocytes (skin cells) are highly specialized epithelial cells designed to perform avery specific
function, separation ofthe organism from its environment. lb accomplish this the cells synthesize precur-
sors andassemble them intotwodistinct structures, thecornifiedenvelope andkeratin intermediate filaments.
The intermediate filaments are assembled from keratin monomers and the cornified envelope is assembled
from aprotein called involucrin and several otherproteins. Expression ofinvolucrin and the keratins genes
are regulated as a function ofthe stage ofkeratinocyte differentiation and by various external agents such
as calcium andvitamin A. lo studythe function ofthese structures andthe regulation ofprecursorproduc-
tion we have cloned cDNA and genomic clones encoding involucrin and four ofthe keratin polypeptides.
Retinoids profoundly alter the differentiation pattern of human epidermal keratinocytes, but the under-
lying biochemical basis ofthis change is not known. In this report we describe retinoid-promoted changes
in keratin gene expression that may, in part, be responsible for the alteration in cellular phenotype in the
presence ofthe vitamin. We also describe the novel structure ofthe human 40 kD keratin, a member ofthe
keratin family that is retinoid responsive and is likely to be important duringepidermal development. Finally,
we describe the structure ofthe envelope precursorprotein, involucrin, as determinedfrom its DNAsequence
and speculate on its role in cornified envelope formation.
Introduction
The skin provides a vitally important protective sepa-
ration between the internal and external environments.
Itis astratified squamous epithelium consistingofseveral
cell types including Langerhans cells, melanocytes, and
keratinocytes. By far, the most abundant cell type is the
keratinocyte (1), which synthesizes major structural com-
ponents ofthe epidermal barrier through aprogrammed
process ofdifferentiation. They arise as basal cells at the
innermost layer ofthe epidermis and following cell divi-
sion, some progenyremain inthebasallayer as stem cells
while others migrate into the upper epidermal layers. The
migrating cells ultimately terminally differentiate to forn
the dead surface layer ofthe skin(stratum corneum) and
duringthe transit from the basallayerto the surface the
cells change dramatically bothbiochemically and morpho-
logically (Fig. 1). During this process keratinocytes ini-
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tiate synthesis of important differentiation-dependent
structural and catalyticproteins includinginvolucrin(2,3),
the keratins(4), filaggrin (5), and transglutaminase (6). In
addition, they go through marked morphological and
cytostructural changes (1,7). These changes include the
appearance in the spinous andgranularlayers ofvarious
intracellular lamellar bodies (membrane coatinggranules,
keratohyalingranules, Odlandbodies, etc.)(1). In addition,
desmosomal links appearin the spinous layer(Fig. 1). In
the uppergranularlayer, the nucleolytic andproteolytic
degradation ofthebulkoftheintracellularorganellesand
macromolecules (7) andrelease oflipid-containinglamel-
larbodies(1) occurs. Simultaneously, the keratinsbecome
stabilizedbydisulfidebonds(7)andinvolucrin,theprecur-
sorofthe cornified envelope (2), becomescovalently cross-
linked to membranousproteinsby a calcium activated en-
zyme, transglutaminase, thusformingthe cornified enve-
lope (6,8,9). These events are largely completed in the
stratum lucidum, a transition zone between living and
dead layers ofthe epidermis. The stratum corneum con-
sists primarily of disulfide-linked keratin filaments sur-
rounded by a cross-linked envelope of protein (Fig. 1).
These structures are heldtogetherby desmosomaljunc-
tions and lipids released from the lamellar bodies. A
characteristic feature ofthis process is that it is strictly
regulated intime and space. When this balancedregula-
tion is disturbed, skin disease and diminished barrier
function may ensue.ECKERTAND RORKE
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FIGURE 1. Keratinocyte differentiation in the epidermis.
Despite considerable descriptive information about the
process, there was until recently very little information
concerningits regulation orthe structure ofthe peptides
involved in the process. Ourlaboratory is interested in un-
derstandinghowkeratinsformtheintermediate filaments
in keratinocytes andhowthe keratin genes are regulated
by retinoids and other agents. A discussion of these
aspects will form a major portion ofthis review. We will
also discuss the function ofinvolucrin, the envelope pre-
cursor, in the context ofcurrently available information.
Keratin Peptide Structure and
Filament Formation
Intermediate filaments are structures formed in virtu-
ally all cell types and are intermediate in size between the
actin and tubulin filaments (10). Inepithelial cells, includ-
ingkeratinocytes, these filaments areformedbykeratins
(7), which consist of afamily ofatleast20 closely related
proteins that are expressed in a cell-type specific manner
(11,12). Keratins and all other intermediate filament
precursor proteins have a structure consisting of three
major segments; a non-a-helical head segment, a non-a-
helical tail segment, and an a-helical central rod domain
(13) (Fig. 2). The central a-helical domain contains a hep-
tadrepeated structure ofthe type(abcdefg).where aand
d are nonpolar amino acids. Nonpolar residues placed in
this manner form an inclined hydrophobic stripe that
wraps around the length ofthe a-helix. Proteins contain-
ing this repeated structure wrap around one another by
aligniingthishydrophobic stripe toform acoiled-coil struc-
ture (i.e., two a-helices wound together to form a larger
coil) (13). The coiled coil is further stabilizedby favorable
FIGURE 2. Structure of40 kD keratin. The structure ofthe 40 kD hu-
man keratin iscomparedwiththe structure ofotherkeratinintermedi-
ate filament precursors. Shown are the head and tail segments (sin-
gleline)and therod domain. Thecoiled-coil-forming a-helical segments
within the rod domain, coils 1A, 1B, and 2 are shown as darkened
blocks, and the nonhelical spacerregions, Li and L12, are indicated
by open regions within each block. The a-helical extension ofthe 40
kD keratin is indicatedby the stippled region. The numbers in paren-
theses are those assigned to each keratin according to the catalogof
Moll et al. (11). Two type I (40 and 50 kD) and two type II keratins
(58 and 67 kD) are shown for comparison.
ionic interactions. Keratin filament formation requires the
association oftype I (acidic) and type II (basic) partners
toform the coiled-coil structure. The central core segment
ofthekeratinpeptide isessentialforthispairing, but seg-
ments ofthe non-a-helical end domain may also be impor-
tant. These dimers arethen assembled into atetrameric
structure that islikelytobe the precursorofthe extended
filament (13).
In keratinocytes, four keratins are expressed in abun-
dance. These have molecular weights of50, 58, 56.5, and
67 kD (14). The 50 and58 kD peptides preferentiallypair
invitro, as do the 56.5 and 67 kD peptides. However, the
nature ofthe filaments formed by each pair differs. The
56.5/67 kD pair form large macrofibrillar bundles,
whereas the 50/58kD complexformsrelativelytypical in-
termediate filament structures, as described above. The
macrofibrillar structures formed by the 56.5 and 67 kD
pair are likely to be important in lending rigidity to the
epidermis. This is the first evidence for a functional dif-
ference between keratin filaments assembledfrom differ-
ent keratins (14). Additional keratins are expressed in
hyperproliferative skin diseases (15), in tumor cells (16),
and in simple epithelial cell types (11). A current area of
interest is whether all keratin pairs or combinations of
pairs have different cellular functions, as has been
described forthe majorepidermnal keratins. Thismightbe
expected, since keratins display marked tissue specific
patterns ofexpression. Later sections will describe the
sequence ofthe40kD keratin, a structurallyunique ker-
atinthat is expressed in squamous cell carcinomas andin
simple epithelial cells. Its structure is unique among all
IF proteins and may suggest a special function (17).
Cornified Envelope Formation
The secondmajor structure elaboratedbykeratinocytes
is the cornified envelope (2). Duringkeratinocyte differen-
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tiation, the cells become increasingly permeable to cal-
ciumandotherions. Asnotedabove, thisoccurs inthe up-
pergranular layer andthe stratum lucidum(Fig. 1). The
mechanism ofthis increased permeability is not known;
it may be aprogrammed part ofkeratinocyte differenti-
ation oritmayresultfromthe action ofsome asyetunde-
fined extracellular trigger. The calcium influx activates
transglutaminase, which then catalyzes formation ofthe
cornified envelope. This envelope consists ofa minimum
ofsevenproteins thatbecome covalently cross-linked into
a stable submembranous structure (2). The mechanism of
envelope formation is largely unknown, but recent find-
ings have suggested some important features ofthe pro-
cess (8,9,18,19) that will be discussed later.
Retinoids Regulate Keratinocyte
Differentiation
Retinoids have beenknown since the early20th century
to profoundly affect epithelial cell organization (20), and
many different cell types are developmentally regulated
by retinoids (17,21-28). Retinoid treatment ofhuman ker-
atinocytes in culture drastically changes the morphology
ofthese cells. The stratification process, shown in Figure
1, is dramatically suppressed, resultingintheappearance
offarfewerlayers (29). As part ofthisinhibition, the corn-
ifiedlayerisreduced orabsentand squame (envelope)for-
mation is reduced 10- to 100-fold (28-30).
Strikingbiochemical changes are alsoproducedbyreti-
noids. Keratin gene expression is markedly altered by
retinoid treatment of cultured keratinocytes (17,22). To
study these effects, we have isolated cDNA (21) and
genomic clones (22) encoding human epidermal keratins
number 5(58 kD), 6(56kD), 13(54kD), and 19(40kD)(21).
These cloneswere selectedforstudybecause two areup-
regulated and two are downregulated by retinoids (22).
Each clone is specific for one keratin as evidencedbyhy-
brid selection ofasingle keratin mRNAandhybridization
to a single band of mRNA in blot hybridization experi-
ments (21,22). All are expressed in cultured human ker-
atinocytes (21,22).
Ibbegin to understand the process ofregulation we have
cultured human keratinoctyes usingthe method ofRhein-
wald and Green(32). Inthis method, the keratinocytes are
cultured on a feeder layer of cobalt-irradiated 3T3 cells.
The 3T3(feeder) cells areirrdiated such thatthey are mi-
totically inactive but metabolically active Thefeeders pro-
vide a supporting matrix for attachment and growth and
may also release some unknown stimulators ofepithelial
cell growth and differentiation.
In our initial experiments, we treated cultured human
keratinocytes with retinol, trans-retinoic acid (tRA), and
a synthetic analogoftRAknown as Ro 13-6298 and moni-
toredthe dose andtime dependence ofchanges inkeratin
peptide andmRNAlevels (22). Retinol promotes changes
in keratin mRNA andprotein levels only at higher doses
(30). Ro 13-6298, by contrast, produces very dramatic
changes(Figs. 3and4). tRAproduces similarchanges, only
it is slightly less potent.
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FIGURE 3. Effect ofretinoid concentration on the content ofindividual
keratins in tracheal and epidermal keratinocytes. Epidermal or
tracheal keratinocytes weretreated for4 daysinthepresence ofthe
indicated concentration ofarotinoid Ro 13-6298. Keratins were elec-
trophoretically separated and then quantitated by Coomassie stain-
ing and laser densitometry (22).
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FIGURE 4. Retinoid effects on keratin mRNA levels. Cultured fetal
tracheal keratinocytes were grown in vitamin A-free medium sup-
plemented with the indicated concentrations ofRo 13-6298. Poly(A)+
RNA was prepared, electrophoresed, transferred to membranes, and
probed with nick-translated probes encoding the 40, 56, and 58 kD
keratins. After exposure ofthe blots on X-ray film, the exposure in-
tensity wasquantitatedbylaserdensitometry (22). Results were simi-
lar with epidermal keratinocytes.
Several mechanistically important features are evident
from these experiments. First, the level of each keratin
changes in parallel with the level of the corresponding
mRNA, suggesting that keratin level is regulated not by
posttranslational mechansims but by control of keratin
mRNA synthesis and/or degradation. Second, these ex-
periments demonstrate that keratin levels can be down-
regulated by retinoids and that changes inmRNA content
mediate the reduction. In fact, as shown in Figure 5, the
total keratin content is drastically reduced in retinoid-
treated cells. This change reducestotal keratin contentto
1/3 the level observed inuntreatedcultures(22). Since ker-
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FIGURE 5. Reduction in total keratin content in cultured keratinocytes
treated with Ro 13-6298. Cells were treated andproteinsquantitated
as described in Fig. 3. Tatal keratin content is plotted as a function
ofdose ofretinoid. The strains are: ir-1,fetal trachealkeratinocyte;
ti-2, fetal trachealkeratinocyte; Tr-V, adulttrachealkeratinocyte; Epi-
AR epidermal keratinocyte.
atinscomprise 10 to 20% ofthetotalprotein content ofcul-
tured keratinocytes, this is a reduction that substantially
alters the protein composition ofthe cell. Third, there is
a coordinate regulation of keratin mRNA and protein
levels in opposite directions, with the 40 and 54 kD kera-
tins increasing and the 56 and 58 kD (and other keratins)
decreasing. We arecurrentlyinvestigating whether these
changes are due to regulation ofRNA synthesis, turnover,
or both. The simplest explanation for the coordinate pat-
ter ofsimultaneous up/downregulation ofthese genes is
that the same factor affects the expression ofeach gene at
some commonpoint in the vitaminAregulatory pathway.
One possibility is that simultaneous activation oftranscrip-
tion of one set ofgenes and suppression ofthe second set
is mediatedby a common regulatoryprotein(trmn-acting
factor)plus the appropriate anclary factors. Alternatively,
the modulation may involve direct regulation of mRNA
turnover. Aninteresting, but lesslikelypossibility, is that
the genes are regulatedby two distinctpathways, each of
which has very similar sensitivity to retinoid. In this
scheme, one mRNA species may be elevatedby increased
synthesis (pathway one), and another may be elevated by
changes in mRNA stability/processing (pathway two). If
this is so, itis simplest to assume that vitamin Amodula-
tion ofthe mRNAlevels ofeachgroup ofkeratins (stimu-
lated and suppressed)wouldbe mediated solelyby one or
the othermechanism. Experimentsinprogress should dis-
tinguish among these possibilities.
The kinetics ofthe responses to retinoid shown in Fig-
ure 6 indicate that the cells respond to very low levels of
retinoid and that aplateau in stimulation is reached after
which there is no further increase. This shows that there
is no toxic downregulation at pharmacological concentra-
tions ofretinoid and suggests that some step in the reti-
noid response pathway becomes rate-limiting around 10
nM retinoid. As shown in Figure 4, at low concentrations
of Ro 13-6298 (10-1 and 10 -1o M) there is an increase in
the level of56 and 58 kD keratin mRNAs. This increase
suggests that the control cells (grown in vitamin A free
medium)are actually vitaminA deficient andthatlow con-
centrations ofretinoid are necessary for maintaining op-
timal expression ofthese keratins. This transient increase
isnotreflected attheproteinlevel(Fig. 3)forreasons that
are related to the differentiated status of the cells (22).
Time course studies shown in Figure 6 indicate that the
genes are not fully activated/suppressed for2 days follow-
ing retinoid administration, suggesting that there are in-
termediate stepsbetween retinoidinteraction with the cell
and activation/suppression ofthe keratin genes. A defmi-
tive answerto this questionwill, however, require the use
ofmore sensitive assays to look at earliertimes. Keratino-
cytes are known to contain the cellularretinoic acid bind-
ing protein (cRABP) (33) found in many cell types and
thought to mediate retinoid responses. Thisparticularmol-
ecule is a20kDprotein thathas anaffinityforretinoic acid
inthenanomolarrange(34). Thus, theaffinity ofthispoten-
tial mediatormatches the dose ofretinoidrequired to ini-
tiate changes in keratin gene expression (22), but no evi-
dence currently exists to confirm its direct involvement.
Iftherecently describedretinoidreceptor(23)isexpressed
in keratinocytes, it may also be important.
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FIGURE 6. Time course of changes in keratin mRNA content in ker-
atinocytes treated with Ro 13-6298. Cultured keratinocytes were
treated with 20 nM Ro 13-6298 for 1 to 5 days. Poly (A) + RNA was
prepared, electrophoresed, transferred to membranes, and probed
with nick-translated probes encodingthe 40, 56, and 58 kD keratins.
After exposure ofthe blots on X-rayfilm, the exposure intensity was
quantitated by laster densitometry (22). Results were similar with
epidermal keratinocytes.
/ 40 kDo (19)
112
c%NnDIFFERENTIATION OF EPITHELIAL CELLS
40 kD Keratin Has a Novel Structure
Intermediate filament proteins are expressed in virtu-
ally all cell types, and keratins are the precursors ofthese
filaments in epithelial cells (11,12,35). These proteins inte-
grate intracellular space and form a network that lends
structural strength to the keratinocyte. Thus, the termi-
nally differentiated keratinocyte has anetworkofdisulfide
cross-linked keratin intermediate filaments that comprise
the bulk of intracellular protein. We have sequenced
several ofthese keratins in an effort to determine whether
the individual structure ofeach is related to its function.
As discussed above, one of the primary effects of reti-
noids on keratin gene expression is upregulation of the
level ofthe 40kD keratin anditsmRNA(21,22). This ker-
atin is increased 10- to 40-fold within 2 days after adding
20 nM Ro 13-6298 to the cultures (21). Inunstimulated cells
it is relatively unabundant, representing much less than
0.1% oftotal cell protein. It is in many ways aunique ker-
atin in that it is the only one that does not have a type II
partner, it is the smallest keratin, it is the first keratin to
appear during development, andprobably the mostprimi-
tive phylogenetically (12).
The 40 kD keratin is expressed in epidermal keratino-
cytes in culture following treatment with retinoids (22), in
transformed cells (36), and in simple epithelial cells (11). As
part of our studies aimed at elucidating the function and
regulation ofthese genes andproteins, we have sequenced
the coding and 5' upstream regions ofthe 40 kD keratin
(17). When compared to otherkeratins, orforthat matter,
all other intennediate filaments, the 40 kD keratin (kera-
tin #19) (11) has a unique structure (17) (Fig. 2) in that it
lacks anon-a-helical tail domain. Initsplace is a 13 amino
acid a-helical extension that retains the heptad structure
in phase with the coiled segments.
As mentioned previously, the tissue-specific pattern of
keratin expression suggeststhat keratins mayhave unique
functions (11,12). The a-helical core appears to be neces-
sary for keratin coiled-coil formation (13). The head and tail
regions appear to be less involved in keratin pairing and
filament formation and may be more important for inter-
action ofthefilaments with cellular structures. The obser-
vationthatintwo distantly related species, the human and
bovine, the40kD keratins are highlyidentical(nearly90%
identity throughout theentirelength) suggests thatithas
an essentialfunction(17). The unique structure ofthis ker-
atin may, atleastinpart, be responsibleforthe alterations
in cell morphology and function associated with its pres-
ence intransformedcells(27)andretinoid-treatedkeratino-
cytes (22).
The a-helical extension ofthe 40 kD keratin extends only
13 amino acids and is under structural constraint due to
its a-helical nature. This unusual tail segment could alter
the properties ofthe keratin filaments containing the 40
kD keratin orthe interaction ofsuchfilaments with other
cellular structures. Theprecise role ofthiskeratininmedi-
ating changes in cell structure and function will require
further investigation.
Formation of Cornified Envelopes
The cornified envelope in keratinocytes is formed dur-
ingthe terminal stages ofkeratinogte differentiation(2,7).
Asthe cellsmigrateintotheupperskinlayerstheybecome
morepermeable to calcium and otherions (7). The result-
ing calcium influx is responsible for activation of a
keratinocyte-specific transglutaminase that catalyzes for-
mation ofthe envelope (2,6) (Fig. 7). A main precursor of
the envelope in human keratinocytes is a 68 kD protein
known as involucrin(2). Involucrin is synthesized as a solu-
ble precursor that is positioned, by an unknown mecha-
nism, adjacenttotheinteriorface oftheplasmamembrane
andthen cross-linked to variousmembrane proteins bythe
keratinocyte-specific transglutaminase (6). The linkage
formed is a y-glutamyl-lysine bond between glutamine
residues on involucrin and primary amino groups of
selected membranous envelope precursor proteins (8,9)
(Fig. 7). The subcellular localization of these precursors
plusthe amino acid sequence ofinvolucrin makes itpossi-
ble to construct a rudimentary model ofenvelope forma-
tion(Fig. 8)thatinvolves theparticipation ofatleasteight
proteins. Seven are located in the membrane, six being
Ca++
FIGURE 7. Mechanism of transglutaminase-mediated formation of isopeptide bonds. The unshadedtransglutaminase isinactive andthe
shaded form is active.
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FIGURE 8. A model ofcornified envelope formation. The closejuxtaposition ofinvolucrin molecules is meant to suggest the possibility of
involucrin homopolymer formation during envelope formation.
membranous precursors ofthe envelope (70, 95, 100, 195,
210and330kD), andthe seventhbeingthe enzymerespon-
sible for synthesis ofthe E-y-glutamyl-lysine bonds (Fig. 7),
transglutaminase (6). The eighth is involucrin.
As intracellular calcium levels increase, presumably by
influx ofextracellular calcium and release from intracellu-
lar stores, transglutaminase is activated andformation of
isopeptide bonds ensues(7). This links the amine acceptor
(involucrin)tothe membrane-associated(amine donor)pro-
teins. Specificmembrane localization oftransglutaminase
hasrecentlybeenreported(6). Itslocalization assures that
cross-linkingwill occurbeneaththeplasmamembrane and
not at other intracellular locations. The presence ofthese
proteins in other compartments couldresultininappropri-
ate cross-linking ofother cellularproteins andorganelles.
The structure ofinvolucrincontributes to itsbeingan ef-
ficient amine acceptor in thecross-linkingreaction (18). In-
volucrin consists ofa series ofapproximately 40highly con-
served repeats of a 10 amino acid sequence having the
consensus sequence (GLU-GLN-GLN-GLY-LEU-LYS-
HIS-LEU)nplus anadditional 19repeatsoflessersimilar-
ity, 15 at the amino and 4 at the carboxyl terminus (18).
Two important features ofthe sequence that are likely to
havefunctionalimplications are apparent. First, glutamic
(GLU) acid and glutamine (GLN) residues are spaced at
equal intervals along the entire length ofinvolucrin. Sec-
ond, theprimary sequence predicts an a-helical structure.
The high content ofglutamic acid(20%o)regularily spaced
along the length ofthe molecule explains why involucrin
and fragments ofinvolucrin migrate as discrete bands on
acrylamidegels inthe absence ofdetergent(19); the nega-
tive chargesapparentlyactlike acoatingofsodiumdodecyl
sulfate. These residues are alsolargely responsible forthe
acid pI of involucrin at 4.5 (2). More importantly, these
negatively chargedgroups arelikelyto have arole inmain-
tainingextension oftheinvolucrin a-helix viaintramolecu-
lar charge repulsion.
The GLNresidues arethereactive(amine acceptor)sites
within the involucrin molecule. Therepeated distribution
and high content (20%) ofGLN residues places potential
amine acceptor sites atregular intervals alongthe entire
length of the involucrin peptide (18), thus potentiating
cross-linking and making these sites accessible to more
than one amine donor. The a-helical structure ofthe mol-
ecule further contributes to the reactivity ofinvolucrinby
providing a conformation in which the GLN and GLU
residues are pointing out away from the axis ofthe helix
and thus enhancing accessibility forreaction. Because in-
volucrin is avery elongated molecule, itispossible to sup-
pose thatitcouldcross-linktwomembraneproteins spaced
at some distance alongthe plane ofthe membrane, creat-
ingavery stableenvelope structure. Itismuchlesslikely
that these functions could be carried out by a globular
(nonelongated) protein or a protein without a regularly
repeating structure.
Manyquestionsremainunansweredconcerningenvelope
production. With the exception of the 195 kD precursor,
whichmaybe aninternally directedperipheralmembrane
protein (37), it is not known whether the membranous
precursors proteins are integral or peripheral proteins
(they are drawn as shown only for convenience). They
clearlyare exposed to the intracellular space, butmay also
project into the extracellular environment. Asignificant in-
tracellular extension could make cross-linking sites avail-
able deep in the cytoplasm.
Second, the sequence ofassembly is not known. Trans-
glutaminases are activated by a calcium-induced change in
conformation andthenreacttoform anacylenzyme inter-
mediate(45). Intheprescence ofamine donorsthe enzyme
thencatalyzesformationofanisopeptidebondbetweenthe
amine donor (glutamyl acceptor) and amine acceptor
(glutamyl donor)before dissociating(Fig. 7). This scheme
requires that involucrin initially bind to the enzyme and
then be transferred to various amine donors. It seems
likely that involucrin is transferred to membranous
glutamyl acceptorproteins based on the acceptors concen-
tration and ability to react with transglutaminase. It is
known thatinvolucrin acts as a substrate atmultiple sites
(19), suggestingthatitmaypotentiallyformmultiple cross-
links simultaneously or sequentially. It can be presumed
thatthere are stericlimitations onthe numberoflinkages
madebyeachinvolucrinmolecule.Transglutaminase may
notbe capable ofaccessingpotential cross-linldng sites af-
ter several proteins have been linked to involucrin. This
hindrance may decelerate the rate ofenvelope formation
as the processproceeds. Afurtherfactorthat mostlikely
limits the extent ofenvelope formation is that the cell is
dying (how fast this occurs is not known), and as a result
114DIFFERENTIATION OF EPITHELIAL CELLS
new precursors and transglutaminase are not being syn-
thesized. In addition, as the membrane is destroyed and
the cross-linking proceeds, the available precursors and
transglutaminase are likely to become less mobile in the
membrane andtherefore less able to react. Third, itis not
known whether any of the membranous precursors are
themselves cross-linked or ifinvolucrin must mediate all
cross-linking events. It does appear, however, that involu-
crin can markedly accelerate and augmenttherate and ex-
tent ofenvelope formation(8), suggestingthatitsprimary
role may be as a facilitator.
Finally, anymodelofenvelope assemblymustexplainthe
progressive thickeningofthe envelope that occurs during
terminal differentiation. The envelope forms in auniform
mannerbeneaththeplasmamembrane withverylittle dif-
ference in depth over its entire circumference. This is a
mechanicalproblemthat canbe stated: How can aprogres-
sively thickening and shape-limiting envelope formbelow
the cell plasma membrane ifthe membranous precursors
are only available in theplasmamembrane? The simplest
explanation is that involcrin homopolymer formation, (in-
volucrin)n, accounts forthe bulk ofthe thickeningthat oc-
curs. Involuciin homopolymers havebeenobservedinvtitro
(8). However, this assumes that involucrin molecules can
get sufficiently close tolinktogetherdespite thehighnega-
tive charge repulsion of the glutamic acid residues.
Another alternative is recruitment of other cytoplasmic
proteins to the envelope. However, available data suggest
thatinvolucrin is the maincytosolic componentofthe enve-
lope (8). A third alternative is that involucrin is first an-
chored to themembrane precursorproteins atone end and
that itthenpoints intothe cell atrightangles tothe mem-
brane, like a dense forest oftree trunks directed into the
cytoplasm. This would place many potential cross-linking
sites inthe cell interiorandwouldalso allowforinvolucrin
homopolymer formation between adjacent involucrin
molecules. This, however, seems unlikely. Assuming a uni-
forrn reactivity ofall potential cross-linlkng sites alongits
length, the probability ofinvolucrin being initially cross-
linkedinthe centralregion ofthe molecule seems aslikely
as this initial linkbeingformed on either end. Invivo, the
involucrin rod is likely to be linked in avariety oforienta-
tions relative to the plane of the membrane.
Regulation of Envelope Formation
Retinoids are potent suppressors ofenvelope formation
inhumankeratinocytes (29). Aremarkable feature ofker-
atinocytephysiology isthe differential effects ofretinoids
on cornifiedenvelope formation andmodulation ofkeratin
gene expression (30). Envelope formation is suppressed
half-maximally at 10- to 100-fold lower concentrations of
retinoidthan the concentrationrequired to modulate ker-
atingene expression(22). This suggests thatthese two sys-
tems arelikely to be controlled via different mechanisms.
Vitamin A has beenreported to exert its effectsby inter-
acting with intracellular binding proteins (38), by mem-
brane effects (38), andby alteringglycoprotein synthesis
(40). The recently cloned retinoid receptor may also have
a role (23). It is currently not known ifany or all ofthese
mechanisms are important in regulatingkeratinocyte func-
tion. Itis conceivable thatmultiplemechanismsare impor-
tant.
Retinoid effects on envelope formation in transformed
keratinocytes hasbeenextensively studiedby Rice and co-
workers(4142)andhave alsobeenexaminedinnormalker-
atinocytes (30). The results argue that the differentiation
process is modified intwowaysin squamous cell carcinoma
(SCC). First, retinoids and culture conditions appearto af-
fectthe levels ofenvelopeprecursors; thatis, these agents
affect their synthesis and/or stability, and second, the
membranes of these cells may not allow calcium influx,
since they do not spontaneouslyform envelopes underany
circumstances. In normal cells, in contrast, there is less
regulation ofenvelope precursorlevels andthemembranes
appear to become spontaneously permeable to calcium
during the course of differentiation.
These data suggest two potential mechanisms for
regulating the extent ofenvelope formation: a)modulation
ofthe levels ofessential precursors, or b) changing mem-
branepermeability to calcium. Theevidence suggeststhat
both mechanisms operate in vivo: There is very little, if
any, involucrin expression in the basal layer in epidermis
(2) orin small (basal) cellsfrom keratinocyte cultures (46).
This profile is paralleled by the 195 and 210 kD mem-
branous precursors of the envelope (9) and by trans-
glutaminase (6). Although we know ofno direct evidence
ofchanges in membrane permeability during differentia-
tion, thephysiologyofkeratinocyte differentiationindicates
that large changes in membrane permeability do not oc-
curuntil thecellsreachtheuppergranularandtransitional
layers when changes in membrane permeability alter
transglutaminase activity andpromote organellar destruc-
tion. Thus, envelope precursorlevels are regulated during
early and intermediate stages in differentiation, but ma-
jor changes in membrane perrneability occur only later
during terminal differentiation.
Summary
In recentyears muchprogress has been made in ourun-
derstanding ofthe molecular events underlying differen-
tiation in epidermis. We now know that keratinocyte
differentiation is enchancedby calcium (43), hydrocortisone
(41,42), and vitamin A depletion (21,22,44) and that
differentiation isgenerally suppressedbyretinoids(22)and
low calciumlevels(43). Progress has also beenmade in un-
derstanding the regulation ofgenes expressed in human
keratinocytes (21,22) and in elucidating their structure
(17,18) andfunction(14). Otherparticipantsinvolved inker-
atin filament assembly and cornified envelope formation
have also been identified (5,8,9). Future experiments can
be expectedto describe in everincreasingdetailthe func-
tion ofthese proteins in the differentiating keratinocyte.
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